IO Biotech, Inc. 8-K

What Happened

• IO Biotech, Inc. (IOBT) filed a Current Report on Form 8-K on January 21, 2026, stating that the company issued a press release announcing it plans to explore strategic alternatives.
• The press release is attached to the 8-K as Exhibit 99.1 and is incorporated by reference; no transaction details, timeline, or parties were disclosed in the filing.

Key Details

• Filing date: January 21, 2026.
• Event reported under Item 8.01 ("Other Events") of Form 8-K.
• The company attached a press release as Exhibit 99.1; no additional financial statements or agreements were filed in connection with this announcement.

Why It Matters

• A review of strategic alternatives signals management is evaluating options that could affect the company’s future direction and shareholder value.
• For investors, the announcement is material because it may precede potential actions such as partnerships, transactions, restructurings, or other changes—though IO Biotech did not provide specifics or a timeline in this filing.
• Investors should watch for follow-up disclosures (amendments to the 8-K, further press releases, or filings) that would provide concrete details on any transactions or decisions.